Blood tests are just a breath away

DUBAI - Blood tests to measure aldehydes will be soon replaced by just breathing into a machine known as “Revelar”, the latest global medical technology revolution, that can diagnose sickness, blood deficiencies and lung cancer in seven minutes.

By Lily B. Libo-on

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Published: Sat 28 Jan 2012, 10:36 PM

Last updated: Fri 3 Apr 2015, 4:49 PM

By April this year, the Revelar system will be rolled out in the UAE, and if used in testing centres and hospitals, Dubai residents may not be queuing up for their turn to take the blood test.

Launched in Dubai on Tuesday night at the Le Meridien Hotel, the US-based Pulse Health’s Revelar system is a new milestone in medical technology that can diagnose a person’s wellness or illness by tracking aldehydes, or organic compounds released when cell damage occurs in a body.

Alaa Altaher, CEO of Pharmaplus, regional distributor of Revelar, told Khaleej Times that aldehydes are evidence of cellular injury, and many are also highly toxic themselves. “The Revelar score is a measurement tool to give patients a very specific method to measure aldehydes, help reduce free radical damage and ultimately improve health. If a doctor has this data in his hand, then he will be able to prescribe appropriate antioxidants and enzymes, or give stress reduction advice and suggest appropriate exercises to alter the score and help in improving the wellness of a patient.”

He said that “Revelar” is a breakthrough breath technology that accurately detects and measures the presence of aldehydes, which are indicators of free radical damage in a body. “The Revelar system measures volatile and often toxic aldehydes that exit a body through exhaled breath. The technology uses a Revelar Breath Tube to capture these aldehydes in a unique manner and come up with a Revelar Score, which reflects breath aldehydes in the parts-per-billion range,” he said.

He also said that the device is simple to use, and takes less than seven minutes to get a personal score, which helps to detect oxidative stress in the human body.

Set to be introduced in the Middle East and North Africa region for the first time, beginning April this year by Pharmaplus, Altaher said, the device is currently in the registration process with the UAE Ministry of Health.

Altaher said that the device is being registered in the Grade 1 category and will be rolled out in phases in the UAE and the region. “We will roll out Revelar in the hospitals first, and then target corporates and insurance companies,” he said.

Pulse Health, the owners of the Revelar device, is in the process of launching other medical devices that use breath-analysers. It is also planning global launch of two devices shortly, one that will measure cholesterol and another that would measure blood pressure, both using breath technology.

More news from